• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Use of a protocol to minimize hypersensitivity reactions with asparaginase administration.

作者信息

Bryant R

出版信息

J Intraven Nurs. 2001 May-Jun;24(3):169-73.

PMID:11530362
Abstract

Several antineoplastic drugs in clinical use may cause hypersensitivity reactions (HSRs) that range from an occasional individual reaction to a significant HSR. Asparaginase preparations have a high incidence of invoking HSRs. The use of an HSR protocol may minimize symptoms experienced by the patient and ensure rapid implementation of life-saving measures when reactions occur. The article will define HSRs, review occurrences, and include a protocol developed to minimize reactions to asparaginase preparations.

摘要

相似文献

1
Use of a protocol to minimize hypersensitivity reactions with asparaginase administration.
J Intraven Nurs. 2001 May-Jun;24(3):169-73.
2
Infusion reactions triggered by monoclonal antibodies treating solid tumors.治疗实体瘤的单克隆抗体引发的输注反应。
J Infus Nurs. 2008 Mar-Apr;31(2):74-83. doi: 10.1097/01.NAN.0000313654.57786.bb.
3
Carboplatin hypersensitivity reactions.卡铂过敏反应。
Clin J Oncol Nurs. 2006 Oct;10(5):595-8. doi: 10.1188/06.CJON.595-598.
4
Hypersensitivity reaction to paclitaxel: nursing interventions.对紫杉醇的过敏反应:护理干预措施
Clin J Oncol Nurs. 2000 Jul-Aug;4(4):161-3.
5
Managing hypersensitivity to asparaginase in pediatrics, adolescents, and young adults.小儿、青少年和青年人群中天冬酰胺酶超敏反应的管理。
J Pediatr Oncol Nurs. 2013 Mar-Apr;30(2):63-77. doi: 10.1177/1043454212471728. Epub 2013 Feb 4.
6
Outcomes and safety of rapid desensitization for chemotherapy hypersensitivity.化疗药物过敏的快速脱敏治疗的结果和安全性。
Expert Opin Drug Saf. 2010 Jan;9(1):39-53. doi: 10.1517/14740330903446936.
7
Hypersensitivity reactions to asparaginase therapy in acute lymphoblastic leukemia: immunology and clinical consequences.急性淋巴细胞白血病中亚 asparaginase 治疗的过敏反应:免疫学和临床后果。
Future Oncol. 2022 Mar;18(10):1285-1299. doi: 10.2217/fon-2021-1288. Epub 2022 Feb 2.
8
Prevention and management of antineoplastic-induced hypersensitivity reactions.抗肿瘤药物引起的超敏反应的预防与管理。
Drug Saf. 2001;24(10):767-79. doi: 10.2165/00002018-200124100-00005.
9
Managing drug infusion reactions: focus on cetuximab monoclonal antibody therapy.管理药物输注反应:聚焦西妥昔单抗单克隆抗体疗法。
Clin J Oncol Nurs. 2008 Jun;12(3):530-2. doi: 10.1188/08.CJON.530-532.
10
Rapid desensitization for hypersensitivity reactions to chemotherapy agents.化疗药物超敏反应的快速脱敏治疗。
Curr Opin Allergy Clin Immunol. 2006 Aug;6(4):271-7. doi: 10.1097/01.all.0000235900.57182.15.

引用本文的文献

1
Safety evaluation of the food enzyme asparaginase from the non-genetically modified strain ARY-2.来自非转基因菌株ARY-2的食品酶天冬酰胺酶的安全性评估。
EFSA J. 2025 Jul 30;23(7):e9532. doi: 10.2903/j.efsa.2025.9532. eCollection 2025 Jul.
2
Safety evaluation of the food enzyme asparaginase from the non-genetically modified strain ARY-1.来自非转基因菌株ARY-1的食品酶天冬酰胺酶的安全性评估。
EFSA J. 2025 Jul 14;23(7):e9533. doi: 10.2903/j.efsa.2025.9533. eCollection 2025 Jul.
3
Safety evaluation of the food enzyme asparaginase from the genetically modified strain ASP.
来自转基因菌株ASP的食品酶天冬酰胺酶的安全性评估。
EFSA J. 2024 Jul 15;22(7):e8874. doi: 10.2903/j.efsa.2024.8874. eCollection 2024 Jul.
4
Safety evaluation of the food enzyme asparaginase from the genetically modified strain AGN.来自转基因菌株AGN的食品酶天冬酰胺酶的安全性评估。
EFSA J. 2024 Feb 20;22(2):e8617. doi: 10.2903/j.efsa.2024.8617. eCollection 2024 Feb.